Traders Purchase Large Volume of Put Options on Centene (NYSE:CNC)

Centene Corporation (NYSE:CNC) was the target of some unusual options trading activity on Tuesday. Traders purchased 22,328 put options on the stock. This is an increase of 67% compared to the average volume of 13,355 put options.

Institutional Investors Weigh In On Centene

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Addison Advisors LLC lifted its position in Centene by 455.6% in the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after buying an additional 606 shares during the last quarter. DV Equities LLC acquired a new stake in shares of Centene during the fourth quarter valued at about $26,000. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in shares of Centene in the 3rd quarter valued at approximately $27,000. IFC & Insurance Marketing Inc. purchased a new position in shares of Centene during the 4th quarter worth approximately $28,000. Finally, SBI Securities Co. Ltd. increased its holdings in Centene by 118.4% in the 4th quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after purchasing an additional 406 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Stock Performance

Shares of Centene stock opened at $36.35 on Wednesday. The business’s 50 day moving average price is $43.20 and its 200 day moving average price is $38.33. The company has a market cap of $17.88 billion, a price-to-earnings ratio of -2.67, a PEG ratio of 0.96 and a beta of 0.48. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.10 and a current ratio of 1.10. Centene has a one year low of $25.08 and a one year high of $66.03.

Centene (NYSE:CNC) last issued its earnings results on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The company had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. During the same period in the prior year, the business earned $0.80 EPS. The firm’s quarterly revenue was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, research analysts predict that Centene will post 6.86 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on CNC shares. Wells Fargo & Company set a $44.00 price target on shares of Centene and gave the stock an “equal weight” rating in a research report on Wednesday, February 18th. JPMorgan Chase & Co. increased their target price on Centene from $38.00 to $45.00 and gave the company a “neutral” rating in a report on Thursday, January 22nd. Morgan Stanley lifted their price target on Centene from $38.00 to $45.00 and gave the stock an “equal weight” rating in a research note on Wednesday, March 4th. Argus upgraded Centene to a “hold” rating in a research report on Monday, February 9th. Finally, Robert W. Baird raised their price objective on Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Three research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $42.06.

Key Stories Impacting Centene

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Centene’s Texas unit, Superior HealthPlan, added a Foster Care Center of Excellence in the Rio Grande Valley—a local operational win that supports member engagement in a core managed‑care market. Superior HealthPlan Names Cute Pediatrics
• Positive Sentiment: Management reaffirmed its 2026 outlook and completed debt note redemptions, which reduces refinancing risk and signals confidence in the company’s capital plan. That helps offset some headline pressure. Centene Reaffirms 2026 Outlook
• Positive Sentiment: Some research services still highlight Centene as a momentum-ranked name, which could attract tactical buyers if sentiment stabilizes. Centene is a Top-Ranked Momentum Stock
• Neutral Sentiment: Centene presented at the Barclays Healthcare Conference; the transcript provides management commentary investors can parse for member trends and margin outlook. Barclays Conference Transcript
• Neutral Sentiment: Analysts’ consensus remains cautious with a general “Hold” stance, limiting immediate upward pressure from upgrades. Consensus “Hold” Rating
• Neutral Sentiment: Market commentary notes Centene has underperformed the Nasdaq recently, signaling relative weakness versus the market but not new company‑specific news. Is Centene Underperforming the Nasdaq?
• Negative Sentiment: Company executives warned of a steeper-than-expected drop in Obamacare memberships, a direct negative for revenue and margin assumptions in segments tied to ACA enrollment. That disclosure is the primary driver of the selloff. Centene Shares Fall on ACA Membership Drop
• Negative Sentiment: Broader reporting shows Obamacare enrollment is plunging as costs rise, a sector headwind hitting Centene and peers and pressuring revenue forecasts. Obamacare Enrollment Plunging
• Negative Sentiment: Analysts and headlines note CNC’s large share decline over the past year and continued downside pressure today, reinforcing negative sentiment among investors. Why Is Centene Stock Falling?
• Negative Sentiment: Unusually heavy put‑option volume indicates traders are positioning for further downside in CNC, amplifying intraday selling pressure. (Options flow data)

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.